Skip to main content
Year archive

NEURIZON THERAPEUTICS LIMITED — 2016 filings

All 39 regulatory filings released by NEURIZON THERAPEUTICS LIMITED (NUZ) in 2016, sourced directly from the official regulator.

39 Filings
2016 Period
2016 filings (39)
Filing Released Lang
PharmAust raises a further $1.56m 1 page 238.2KB
Capital/Financing Update
2016-12-29 English
Change of Director's Interest Notice x 4 10 pages 534.9KB
Director's Dealing
2016-12-12 English
Completion of Rights Issue & Notice of Shortfall 1
Capital/Financing Update
2016-12-07 English
No Extension of Closing Date in Rights Issue 1 page
Capital/Financing Update
2016-12-05 English
Rights Issue - Extension of Closing Date 1 page 332
Capital/Financing Update
2016-12-04 English
Phase II Strategy Update 1 page 366.8KB
Capital/Financing Update
2016-11-20 English
PharmAust AGM Presentation 19 pages 1.6MB
Investor Presentation
2016-11-10 English
Results of Annual General Meeting 1 page 90.7KB
Declaration of Voting Results & Voting Rights Announcements
2016-11-10 English
Prospectus 32 pages 549.4KB
Capital/Financing Update
2016-11-07 English
Letter to Optionholders 2 pages 141.2KB
Capital/Financing Update
2016-11-07 English
Appendix 3B 12 pages 732.5KB
Capital/Financing Update
2016-11-07 English
Appendix 4C - Quarterly Report & Company Update 7 pages 520.3KB
Interim / Quarterly Report
2016-10-30 English
Second canine receives treatment in trial 1 page 24
Regulatory Filings
2016-10-13 English
Notice of Annual General Meeting/Proxy Form 15 pages 382.8KB
AGM Information
2016-10-10 English
Phase II Canine Trial begins at University of Cambridge 1
Regulatory Filings
2016-09-18 English
Epichem achieves ISO 9001 2015 certification 2 pages 334.7KB
Regulatory Filings
2016-09-15 English
MPL capsules shipped to centres in NSW & Qld for Phase II 1
Regulatory Filings
2016-09-12 English
Appendix 4E & Full Year Statutory Accounts 2016 53 pages 950.4KB
Annual Report
2016-08-30 English
Appendix 4G & Corporate Governance Statement 20 pages 634.0KB
Regulatory Filings
2016-08-30 English
PharmAust Investor Presentation - August 2016 19 pages 911.0KB
Investor Presentation
2016-08-28 English
Further Canine Trials to be Initiated in Australia 1
Regulatory Filings
2016-08-09 English
IP exchange with UNSW consolidates MPL patent position 1
Regulatory Filings
2016-08-02 English
Appendix 4C Quarterly & Brief Company Update - June 2016 7 pages 534.9KB
Interim / Quarterly Report
2016-07-28 English
Reformulated MPL capsules completed, Phase II to commence 2 pages 251.7KB
Regulatory Filings
2016-07-10 English
University of Cambridge to begin Phase II Trial 1 p
Regulatory Filings
2016-06-26 English
Epichem Successful in AusTrade Grant 2 pages 243.7KB
Regulatory Filings
2016-06-15 English
Mandate signed to raise capital in USA & list on NASDAQ 2 pages 247.9KB
Capital/Financing Update
2016-06-01 English
Appendix 4C Quarterly Report & Brief Company Update 7 pages 536.2KB
Interim / Quarterly Report
2016-04-28 English
RedChip issues research on PharmAust 2 pages 427.4KB
Regulatory Filings
2016-03-10 English
Strategy for Phase II Clinical Trial of Monepantel 1
Regulatory Filings
2016-03-07 English
Appendix 4D & Half Yearly Report and Accounts 19 pages 627.3KB
Interim / Quarterly Report
2016-02-28 English
PharmAust Featured on The RedChip Money Report on Bloomberg 1
Regulatory Filings
2016-02-11 English
PharmAust to Present at RedChip Global Online Microcap Conf 1
Investor Presentation
2016-02-07 English
Notice of Allowance received from USA Patent OffIce 1
Regulatory Filings
2016-02-04 English
PharmAust Receives $546K R&D Rebate from ATO 1 page
Capital/Financing Update
2016-01-31 English
Appendix 4C - Quarterly Report & Company Update 7 pages 474.8KB
Interim / Quarterly Report
2016-01-28 English
USA Roadshow Presentation - January 2016 21 pages 678.6KB
Investor Presentation
2016-01-17 English
Juniper Pharma Services to reformulate MPL for Phase II 2 pages 412.0KB
Regulatory Filings
2016-01-10 English
PharmAust Featured on RedChip Money Report on Bloomberg 1
Regulatory Filings
2016-01-03 English